
|Videos|May 26, 2017
Improving Radiotherapy Responses in Head and Neck Cancer With Galectin-1
Author(s)Dhanya K. Nambiar, PhD
Dhanya K. Nambiar, PhD, Stanford University, discusses a study exploring galectin-1 in combination with radiation and immune checkpoint therapy in head and neck cancers.



















